Beta-blockers (All routes except ocular) (versus unexposed) updated on 12-17-2024

Cleft palate

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S13907
R54452
Bergman - Beta-blockers, 2018 Cleft palate 1st trimester case control unexposed (general population or NOS) Adjustment: Yes Indications Antihypertensive: All hypertensions, any indications or not specified 1.70 [0.90;3.40] 10/150   1,998/52,567 2,008 150
ref
S13785
R53987
Fisher a - Beta-blockers, 2018 Cleft palate only 1st trimester case control unexposed, disease free Adjustment: Yes Indications Antihypertensive: All hypertensions, any indications or not specified 0.90 [0.40;2.10] 7/-   1,439/- 1,446 -
ref
S13416
R51620
Puho - Metoprolol, 2007 Posterior cleft palate 1st trimester case control unexposed (general population or NOS) Adjustment: Yes Indications Antihypertensive: All hypertensions, any indications or not specified 2.10 [0.80;5.70] 4/124   597/38,628 601 124
ref
Total 3 studies 1.47 [0.92;2.33] 4,055 274
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Bergman - Beta-blockers, 2018Bergman - Beta-blockers, 2018 1.70[0.90; 3.40]2,00815047%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: unclearROB reporting: moderate Fisher a - Beta-blockers, 2018Fisher a - Beta-blockers, 2018 0.90[0.40; 2.10]1,446-31%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: unclearROB reporting: moderate Puho - Metoprolol, 2007Puho - Metoprolol, 2007 2.10[0.80; 5.70]60112422%ROB confusion: criticalROB selection: criticalROB classification: moderateROB missing: moderateROB mesure: criticalROB reporting: moderate Total (3 studies) I2 = 2% 1.47[0.92; 2.33]4,0552740.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0 case control studiescase control studies 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 3 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 3 Tags Adjustment   - Yes  - Yes 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 3 Indications Antihypertensive   - All hypertensions, any indications ...  - All hypertensions, any indications or not specified 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 3 All studiesAll studies 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 30.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.47[0.92; 2.33]4,0552742%NABergman - Beta-blockers, 2018 Fisher a - Beta-blockers, 2018 Puho - Metoprolol, 2007 30.510.01.0